Day: July 18, 2024

‘Breaking Barriers’ Coalition Formed to Address Opioid Use Disorder in the USA Nexalin CEO Mark White Participates in Inaugural Meeting HOUSTON, TX, July 18, 2024 (GLOBE NEWSWIRE) — Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) today announced that it has been selected to serve as a founding member of Breaking Barriers to Substance Use Recovery, a coalition of major industry participants and preeminent healthcare providers. Established as a tax-exempt organization, Breaking Barriers to Substance Use Recovery is focused on identifying and dismantling the obstacles to effective treatment for opioid use disorder. Breaking Barriers to Substance Use Recovery brings together bringing together a broad cross section of leaders in the medical and science and technology industries to develop and formulate pioneering...

WOBURN, Mass., July 18, 2024 (GLOBE NEWSWIRE) — Bridgeline Digital, Inc. (NASDAQ: BLIN), a global leader in AI-powered marketing technology, announces that its CEO, Ari Kahn, has been recognized as one of the most innovative leaders to watch in 2024 by Biztech Outlook. Biztech Outlook recognized Kahn as an “AI Pioneer” in a list of the most innovative leaders of 2024. The publication described Bridgeline’s efforts to transform online revenue for customers through HawkSearch’s new Smart Search, which boosts eCommerce sales through concept and visual search. Kahn, with a PhD in Artificial Intelligence, uses his expertise to keep Bridgeline at the cutting edge of AI technology. “Smart Search exemplifies our AI innovation,” said Ari Kahn. “Being recognized as an AI pioneer and an innovative leader is not just a personal...

On Track to generate $2,430,000 rental income for 2024 NEW YORK, July 18, 2024 (GLOBE NEWSWIRE) — JP 3E Holdings, Inc. (OTC: SPZI), formerly known as Spooz, Inc. is excited to announce the addition of our first of several real estate purchases, which falls into the education/real estate platform of JP3E’s three “E’s” platform strategy of combining education, eating and energy under JP3E. The 510 Hamilton Real Estate property was acquired through a signed Membership Interest Purchase Agreement with Hamilton Street Associates, LLC, and was appraised by A.F. Lama Realty Services, Inc. at $37,460,000 with $14,300,000 equity. The 510 Hamilton property is cash flow positive and currently generates approximately $200,000 in monthly income and is on track to generate $2,430,000 annual rental income for 2024. JP3E acquired 510 Hamilton...

As the third and final clinical site, Memorial Sloan Kettering Cancer Center joins Brigham Women’s Hospital and Baptist Hospital of Miami as sites for the pivotal human clinical trial BRAINTREE, Mass., July 18, 2024 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic Surgical System, today announces it has received Institutional Review Board (IRB) approval and signed a clinical trial agreement with Memorial Sloan Kettering Cancer Center, located in New York City, New York. Memorial Sloan Kettering Cancer Center will conduct the clinical trial as part of the Investigational Device Exemption (“IDE”) for LIBERTY®, and the Company expects its results will support the future marketing submission to the FDA and subsequent commercialization. The clinical trial at Memorial...

HOUSTON, July 18, 2024 (GLOBE NEWSWIRE) — Intuitive Machines, Inc. (Nasdaq: LUNR, LUNRW) (“Intuitive Machines”) (“Company”), a leading space exploration, infrastructure, and services company, has finalized the IM-2 mission landing region ahead of its sold-out IM-2 mission. The IM-2 mission is designed to prospect for water ice and other volatiles on the Moon’s south pole, which requires a landing site that supports the high probability of ice stability within one meter of the lunar surface. Working with NASA, Intuitive Machines selected a 200-meter diameter elliptical region on the Shackleton Connecting Ridge with favorable terrain, Earth communications position, and solar angles for power generation. To align with the landing site’s solar power conditions, the mission must be timed between November 2024 and January 2025, IM-2...

Brad Hauser, Chief Executive Officer of Autonomix, discusses the Company’s agreement to license FDA-cleared ablation technology from RF Innovations, Inc. THE WOODLANDS, TX, July 18, 2024 (GLOBE NEWSWIRE) — Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced that it recently participated in a Virtual Investor “What This Means” segment. For the segment, Brad Hauser, Chief Executive Officer of Autonomix, discussed the Company’s recently announced definitive agreement with RF Innovations, Inc., a privately held medical technology company, to license the intellectual property underlying its Apex 6 Radiofrequency Generator and what this agreement...

Company poised to execute additional cGMP activities throughout the remainder of the year DURHAM, N.C., July 18, 2024 (GLOBE NEWSWIRE) — Scorpius Holdings, Inc (NYSE American: SCPX), (“Scorpius” or the “Company”), an integrated contract development and manufacturing organization (CDMO), today announced the successful execution of its first current Good Manufacturing Practice (cGMP) microbial batches at its San Antonio manufacturing facility. This significant milestone marks the beginning of Scorpius’ support for manufacturing programs through clinical manufacturing, with aspirations for future commercial activities. Scorpius’ facilities have already attracted significant interest, resulting in a substantial backlog of client program bookings. This achievement underscores Scorpius’ ability to meet the stringent regulatory...

NEW YORK, July 18, 2024 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the successful completion of biocompatibility testing of its Intelligent Fingerprinting Drug Screening System, a pivotal phase in the clinical study plan required for FDA 510(k) regulatory clearance. The biocompatibility study, conducted in accordance with ISO 10993 standards, involved a thorough evaluation of the system’s materials that come into contact with human skin. With the successful completion of the biocompatibility study, INBS has confirmed that all materials used in its system, including the Drug Screening Cartridge, Confirmatory Cartridge and the DSR-Plus Reader, are...

Clermont-Ferrand, July 18, 2024 COMPAGNIE GÉNÉRALE DES ÉTABLISSEMENTS MICHELIN Initiation rating from Scope Ratings and upgrade from Moody’s Ratings On July 12, 2024, the European rating agency Scope Ratings published a solicited rating report on Michelin (Compagnie Générale des Etablissements Michelin and its main financial subsidiaries): long-term rating of A with a Stable outlook and short-term rating of S-1. “The issuer rating reflects Michelin’s strong business risk profile as a leading global tyre manufacturer and an even stronger financial risk profile, supported by low leverage” Scope mentioned in its press release. The agency’s rating report is available at  www.scoperatings.com On July 11, 2024, Moody’s upgraded Michelin long-term rating to A2 with a Stable Outlook, from A3 with a Stable outlook, “reflecting the group’s track...

CINCINNATI, July 18, 2024 (GLOBE NEWSWIRE) — Workhorse Group Inc. (Nasdaq: WKHS) (“Workhorse” or “the Company”), an American technology company focused on pioneering the transition to zero-emission commercial vehicles, today announced McAbee Trucking, Inc., a pioneer in the operation of alternative fuel trucks on Star Carrier Mail Contractor Routes, has taken a step forward in sustainable transportation by acquiring a new all-electric W4 CC box truck from Workhorse. This purchase marks McAbee Trucking’s first addition of an electric vehicle to their fleet, following a successful demonstration period that showcased the capabilities and benefits of Workhorse’s W4 CC. The decision to acquire a W4 CC was driven by the impressive performance observed during the demo, validating the reliability and efficiency of the Workhorse electric...